BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 9, 2012, Pages 1657-1663

  Grigoriou, Eirini E ^a   Psarra, Katerina K ^a   Garofalaki, Maria K ^a   Tziotziou, Eirini C ^a   Papasteriades, Chryssa A ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

BCR ABL protein; Flow cytometry; Precursor B cell acute lymphoblastic leukemia

Indexed keywords

BCR ABL PROTEIN; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRIC IMMUNOBEAD ASSAY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 84867821905     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0686     Document Type: Article

References (22)

1. Nowell P, Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science 1960;132:1497-501.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Guiemsa staining [Letter]. Nature 1973;243:290-3.
3. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-84.
4. Gleissner B, Gökbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood 2002;99:1536-43.
5. Pui CH, Crist WM, Look T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990;76:1449-63.
6. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV. Philadelphia positive acute lymphoblastic leukaemia in adultsage distribution, BCR breakpoint and prognostic significance. Leukemia 1991;5:196-9.
7. Rieder H, Bonwetsch C, Janssen LA, Maurer J, Janssen JW, Schwartz S, et al. High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia 1998;12:1473-81.
8. Pui CH, Relling MV, Pharm D, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-48.
9. Secker-Walker LM, Pentrice HG, Durrant J, Richards S, Hall E, Harrison G. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA. Br J Haematol 1997;96:1449-63.
10. Faderl S, Kantarjian HM, Thomas DA, Cortes J, Giles F, Pierce S, et al. Outcome of Philadephia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma 2000;36:263-73.
11. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K, et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004;18:895-908.
12. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96:3343-56.
13. Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-28.
14. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of "real-time" quantitative reverse transcriptase polymerase chain reaction of fusion gene transcript for residual disease detection in leukemia a Europe Against Cancer program. Leukemia 2003;17:2318-57.
15. Weerkamp F, Dekking E, Ng YY, van der Velden VH, Wai H, Böttcher S, et al. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients. Leukemia 2009;23:1106-17.
16. Dekking E, van der Velden VH, Böttcher S, Brüggemann M, Sonneveld E, Koning-Goedheer A, et al. On behalf of the EuroFlow Consortium. Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay. Best Pract Res Cl Ha 2010;23:333-45.
17. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European group for the immunological classification of acute leukemias (EGIL). Leukemia 1995;9:1783-6.
18. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Scoot E, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using "real-time" quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - A Europe against cancer program. Leukemia 2003;17:2474-86.
19. Gengshen Q, Hotilovak L. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous scale diagnostic test. Stat Methods Med Res 2008;17:207-21.
20. Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane F, et al. The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. Haematologica 2004;89:1269-71.
21. Wassmann B, Pfeifer H, Scheuring UJ, Binckebanck A, Gökbuget N, Atta J, et al. Early prediction of response in patients with relapsed of refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib. Blood 2004;103:1495-8.
22. Raponi S, De Propris MS, Wai H, Intoppa S, Elia L, Diverio D, et al. An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia. Haematologica 2009;94:1767-70.